Biocatalysts and Bioreactor Design
An automated microscale platform for evaluation and optimization of oxidative bioconversion processes
Article first published online: 5 JAN 2012
DOI: 10.1002/btpr.1500
Copyright © 2012 American Institute of Chemical Engineers (AIChE)
Additional Information
How to Cite
Baboo, J. Z., Galman, J. L., Lye, G. J., Ward, J. M., Hailes, H. C. and Micheletti, M. (2012), An automated microscale platform for evaluation and optimization of oxidative bioconversion processes. Biotechnol Progress, 28: 392–405. doi: 10.1002/btpr.1500
Publication History
- Issue published online: 10 APR 2012
- Article first published online: 5 JAN 2012
- Accepted manuscript online: 7 DEC 2011 04:27PM EST
- Manuscript Revised: 30 NOV 2011
- Manuscript Received: 1 AUG 2011
Funded by
- Biotechnology and Biological Sciences Research Council
- Engineering and Physical Sciences Research Council (EPSRC)
- 12 industrial partners supporting the BICE programme
Keywords:
- oxidative bioconversion;
- microscale bioprocessing;
- high throughput;
- automated processing;
- cyclohexanone monooxygenase
Abstract
In this work an integrated robotic platform has been used for the development of a fully automated microscale process sequence comprising fermentation and bioconversion using E. coli TOP10 [pQR210] expressing cyclohexanone monooxygenase (CHMO). Ninety six-Deep Square Well (96-DSW) microtiter plates were used for microbial culture and enzyme-catalyzed conversion, where plate preparation, reagent addition, and sampling were all carried out without manual intervention. The adoption of automated robotic procedures has enabled the rapid collection of kinetic data for whole process optimization at the microscale. This high-throughput approach enabled a range of amino acid sources for media formulation and well fill volumes to be investigated highlighting when nutritional limitation and oxygen limitations took place. The automated process sequence has been applied to test six CHMO substrates including norcamphor and cycloheptanone all of which to the best of our knowledge have yet to be tested with E. coli TOP10 [pQR210]. Substrate specificity and product selectivity were effectively demonstrated and compared to both the natural substrate cyclohexanone and the model substrate bicyclo[3.2.0]hept-2-en-6-one used to demonstrate asymmetric synthesis. The results obtained using the developed process sequence could be reproduced at 75 L scale when a matched oxygen transfer coefficient kLa approach was used. The study demonstrates how automated microscale processing enables the rapid collection of kinetic quantitative data in a robust manner with clear implications for accelerating bioprocess development, optimization, and scale-up. © 2012 American Institute of Chemical Engineers Biotechnol. Prog., 2012

1520-6033/asset/BTPR_left.gif?v=1&s=a5be2ff5a0fe6ccdaad74a6d128c142e5f71a8da)
1520-6033/asset/BTPR_right.gif?v=1&s=992d113a3e61fc9d3571812359165df86cf830e4)
